Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review

Mascolo A, Scavone C, Rafaniello C, Ferrajolo C, Racagni G, Berrino L, Paolisso G, Rossi F, Capuano A.

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19

Cadegiani FA, Wambier CG, Goren A.

Identify the Risk Factors of COVID-19-Related Acute Kidney Injury: A Single-Center, Retrospective Cohort Study

Wang J, Wang Z, Zhu Y, Li H, Yuan X, Wang X, Wang Y, Hu J, Feng C, Liu C, Liu S, Yu K, Li X, Zeng X.

Is therapeutic anticoagulation improving renal outcomes in COVID-19?

Roomi S, Ullah W, Farooq S, Saeed R, Haq S, Ashfaq AA.

DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Smelcerovic A, Kocic G, Gajic M, Tomovic K, Djordjevic V, Stankovic-Djordjevic D, Anderluh M.

Should kidney transplants during the COVID-19 pandemic be canceled or maintained?

Arruda GJF, Arruda Neto JF, Spessoto LCF, Arruda JGF, F√°cio FN Jr.

De Novo ANCA-associated Vasculitis with Glomerulonephritis in COVID-19

Uppal NN, Kello N, Shah HH, Khanin Y, De Oleo IR, Epstein E, Sharma P, Larsen CP, Bijol V, Jhaveri KD.

IgA Vasculitis with Nephritis (Henoch-Schönlein purpura) in a COVID-19 patient

Suso AS, Mon C, Alonso IO, Romo KG, Juarez RC, Ramirez CL, Sanchez MS, Valdivia VM, Librero MO, Pala AO, Marcos OO, Herrero Berron JC, Pascual A.

Challenges in setting up point-of-care hemodialysis in a COVID-19 care facility: Lessons from a limited-resource setting

Bharati J, Ramachandran R, Kumar R, Prakash S, Kohli HS.

COVID-19 and the kidney: A matter of concern

Meena P, Bhargava V, Rana DS, Bhalla AK, Gupta A.

Adrenal insufficiency in coronavirus disease 2019: a case report

Heidarpour M, Vakhshoori M, Abbasi S, Shafie D, Rezaei N.

Targeting of renin-angiotensin system in COVID-19 patients affected by stroke: Emerging concerns about detrimental vs. benefit effect

Luzzi S, Giotta Lucifero A, Marasco S, Del Maestro M, Bellantoni G, Gragnaniello C.

Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort

Xia P, Wen Y, Duan Y, Su H, Cao W, Xiao M, Ma J, Zhou Y, Chen G, Jiang W, Wu H, Hu Y, Xu S, Cai H, Liu Z, Zhou X, Du B, Wang J, Li T, Yan X, Chen L, Liang Z, Zhang S, Zhang C, Qin Y, Wang G, Li X.

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab

Baldallo C, León Román JC, Serón D, Agraz I, Solans R, Ramos N, Soler MJ.

Clinical Profiles in Renal Patients with COVID-19

Arenas MD, Crespo M, Pérez-Sáez MJ, Collado S, Redondo-Pachón D, Llinàs-Mallol L, Montero MM, Villar-García J, Arias-Cabrales C, Barbosa F, Buxeda A, Burballa C, Sans L, Vázquez S, Oliveras A, Mir M, Outón S, Galcerán I, Solá E, Sierra A, Barrios C, Rodríguez E, Cao H, Güerri-Fernández R, Horcajada JP, Pascual J.

Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study

Matsuzawa Y, Ogawa H, Kimura K, Konishi M, Kirigaya J, Fukui K, Tsukahara K, Shimizu H, Iwabuchi K, Yamada Y, Saka K, Takeuchi I, Hirano T, Tamura K.

Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab

Lenti MV, Gregorini M, Borrelli de Andreis F, Rampino T, D'Ambrosio G, Verga L, Vanoli A, Mengoli C, Ravetta V, Paulli M, Di Sabatino A.

Implications of ABO blood group in hypertensive patients with covid-19

Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, Gambardella J, Sardu A, Gatta G, Santulli G, Paolisso G.

Racial and Ethnic Disparities in Seasonal Influenza Vaccination among Dialysis Facilities in the United States

Danziger J, Weinhandl E, Friedman D, Mukamal KJ.

Perspectives on COVID-19 from Singapore: Impact on ESKD Care and Medical Education

Coffman TM, Chan CM, Choong LH, Curran I, Tan HK, Tan CC.

Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis

Taneri PE, Gómez-Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa-Díaz ZM, Salvador D Jr, Groothof D, Minder B, Kopp-Heim D, Hautz WE, Eisenga MF, Franco OH, Glisic M, Muka T.

Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy

Naeem S, Gohh R, Bayliss G, Cosgrove C, Farmakiotis D, Merhi B, Morrissey P, Osband A, Bailey JA, Sweeney J, Rogers R.

Outcomes of patients with end-stage kidney disease hospitalized with COVID-19

Ng JH, Hirsch JS, Wanchoo R, Sachdeva M, Sakhiya V, Hong S, Jhaveri KD, Fishbane S; Northwell COVID-19 Research Consortium and the Northwell Nephrology COVID-19 Research Consortium.

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia

Tatar E, Karatas M, Bozaci I, Ari A, Acar T, Simsek C, Yildirim AM, Yildirim O, Uslu A.

Obstructive sleep apnea, renin-angiotensin system, and COVID-19: possible interactions

Ekiz T, İnönü Köseoğlu H, Pazarlı AC.

Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?

Namsolleck P, Moll GN.

Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19

Megaly M, Glogoza M.

Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients

Chen C, Wang F, Chen P, Jiang J, Cui G, Zhou N, Moroni F, Moslehi JJ, Ammirati E, Wang DW.

The potential effectiveness of acetazolamide in the prevention of acute kidney injury in COVID-19: A hypothesis

Habibzadeh P, Mofatteh M, Ghavami S, Roozbeh J.

Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients

Crespo M, Mazuecos A, Rodrigo E, Gavela E, Villanego F, Sánchez-Alvarez E, González-Monte E, Jiménez-Martín C, Melilli E, Diekman F, Zárraga S, Hernández D, Pascual J; Spanish Society of Nephrology COVID-19 Group.

Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany

Seidel M, Hölzer B, Appel H, Babel N, Westhoff TH; COVID Dialysis Working Group.

COVID-19-related stigma and perceived stress among dialysis staff

Uvais NA, Aziz F, Hafeeq B.

Acute Kidney Injury in COVID-19 Pneumonia: A Single-Center Experience in Bahrain

Taher A, Alalwan AA, Naser N, Alsegai O, Alaradi A.

Hemodialysis in COVID-19 Patients: Yes or No? A Commentary

Hosseini A, Bahramnezhad F.

Peritoneal Dialysis for Acute Kidney Injury during the COVID-19 Pandemic

Shimonov D, Srivatana V.

Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Injury in Kidney Transplant Recipients During the Time of the Coronavirus Disease 2019 Pandemic

Garg N, Hidalgo LG, Aziz F, Parajuli S, Mohamed M, Mandelbrot DA, Djamali A.

Implications of AB0 blood group in hypertensive patients with covid-19

Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, Gambardella J, Sardu A, Gatta G, Santulli G, Paolisso G.

Renal Transplant Recipient with Concurrent COVID-19 and Stenotrophomonas maltophilia Pneumonia Treated with Trimethoprim/Sulfamethoxazole Leading to Acute Kidney Injury: A Therapeutic Dilemma

Mohamed MA, Kaur J, Wani F, Kichloo A, Bhanot R.

COVID Era "Essential Surgery" Dialysis Access Management Considerations

Kirksey L, Vacharajani T, Droz NM, McLennan G, Clair D, Lyden SP.

Telemedicine in the Care of Kidney Transplant Recipients With Coronavirus Disease 2019: Case Reports

Abuzeineh M, Muzaale AD, Crews DC, Avery RK, Brotman DJ, Brennan DC, Segev DL, Al Ammary F.

Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery and filter lifetime

Wilbers TJ, Koning MV.

COVID-19 and the Kidneys: An Update

Benedetti C, Waldman M, Zaza G, Riella LV, Cravedi P.

Authors' Reply

Farkash EA, Wilson AM, Jentzen JM.

Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia

Di Tano G, De Maria R, Loffi M, Moschini L, Galeazzi G, Danzi GB.

COVID-19 in Patients With Renal Cell Carcinoma in the Russian Federation

Tsimafeyeu I, Alekseeva G, Berkut M, Nosov A, Myslevtsev I, Andrianov A, Semenov A, Borisov P, Zukov R, Goutnik V, Savchuk S, Volkova M, Mukhina M.

SARS-CoV-2 Causes a Specific Dysfunction of the Kidney Proximal Tubule

Werion A, Belkhir L, Perrot M, Schmit G, Aydin S, Chen Z, Penaloza A, De Greef J, Yildiz H, Pothen L, Yombi JC, Dewulf J, Scohy A, Gérard L, Wittebole X, Laterre PF, Miller SE, Devuyst O, Jadoul M, Morelle J; CUSL COVID-19 Research Group.

Kidney transplantation during the COVID-19 pandemic: Potential long-term consequences of an early post-transplant infection

Del Bello A, Marion O, Sallusto F, Delas A, Esposito L, Doumerc N, Kamar N.

A simulation modelling toolkit for organising outpatient dialysis services during the COVID-19 pandemic

Allen M, Bhanji A, Willemsen J, Dudfield S, Logan S, Monks T.

Transmission of SARS-CoV-2 Involving Residents Receiving Dialysis in a Nursing Home - Maryland, April 2020

Bigelow BF, Tang O, Toci GR, Stracker N, Sheikh F, Jacobs Slifka KM, Novosad SA, Jernigan JA, Reddy SC, Katz MJ.

The impact of COVID-19 on kidney transplantation

Alasfar S, Avery RK.

Evidence of potent humoral immune activity in COVID19-infected kidney transplant recipients

Hartzell S, Bin S, Benedetti C, Haverly M, Gallon L, Zaza G, Riella LV, Menon MC, Florman S, Rahman AH, Leech JM, Heeger PS, Cravedi P.

ERACODA: the European database collecting clinical information of patients on kidney replacement therapy with COVID-19

Noordzij M, Duivenvoorden R, Pena MJ, de Vries H, Kieneker LM; ERACODA Working Group.

What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19?

Elijovich F, Laffer CL.

Role of the renin angiotensin system in the development of severe COVID-19 in hypertensive patients

Silva-Aguiar RP, Peruchetti DB, Rocco PRM, Schmaier AH, Silva PMR, Martins MA, Carvalho VF, Pinheiro AAS, Caruso-Neves C.

COVID-19 Outbreak in a Hemodialysis Center: A Retrospective Monocentric Case Series

Mazzoleni L, Ghafari C, Mestrez F, Sava R, Bivoleanu E, Delmotte P, Laurent F, Roland T, Rossi C, Carlier S.

Author Correction: COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19

Velez JCQ, Caza T, Larsen CP.

Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection

Martínez-Del Río J, Piqueras-Flores J, Nieto-Sandoval Martín de la Sierra P, Negreira-Caamaño M, Águila-Gordo D, Mateo-Gómez C, Salas-Bravo D, Rodríguez-Martínez M.

Do Lifestyle Changes of Renal Transplant Recipients During the Pandemic Reduce the Risk of Coronavirus Disease 2019?

Hasanoglu I, Bilgic Z, Olcucuoglu E, Karakan MS, Demirci BG, Kalem AK, Kayaaslan B, Eser F, Guner R.

Remote patient monitoring in peritoneal dialysis helps reduce risk of hospitalization during Covid-19 pandemic

Scarpioni R, Manini A, Chiappini P.

COVID-19 in Renal Transplant Patient Presenting With Active Typical Symptoms and Resolved Atypical Symptoms

Adapa S, Konala VM, Naramala S, Daggubati SR, Koduri NM, Gayam V, Chenna A.

What every Intensivist should know about COVID-19 associated acute kidney injury

Ostermann M, Lumlertgul N, Forni LG, Hoste E.

Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient

Babel N, Anft M, Blazquez-Navarro A, Doevelaar AAN, Seibert FS, Bauer F, Rohn BJ, Hoelzer B, Thieme CJ, Roch T, Meister TL, Pfaender S, Steinmann E, Dittmer U, Schenker P, Amann K, Viebahn R, Stervbo U, Westhoff TH.

Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study

Favà A, Cucchiari D, Montero N, Toapanta N, Centellas J, Vila-Santandreu A, Coloma A, Meneghini M, Manonelles A, Sellarés J, Torres I, Gelpi R, Lorenzo I, Ventura-Aguiar P, Cofan F, Torregrosa V, Perelló M, Facundo C, Seron D, Oppenheimer F, Bestard O, Cruzado JM, Moreso F, Melilli E.

In-depth virological assessment of kidney transplant recipients with COVID-19

Benotmane I, Gautier Vargas G, Wendling MJ, Perrin P, Velay A, Bassand X, Bedo D, Baldacini C, Sagnard M, Bozman D, Della Chiesa M, Solis M, Gallais F, Cognard N, Olagne J, Delagreverie H, Gontard L, Panaget B, Marx D, Heibel F, Braun L, Moulin B, Caillard S, Fafi-Kremer S.

Clinical benefits of Tocilizumab in COVID-19-related cytokine release syndrome in a patient with end-stage kidney disease on haemodialysis in Australia

Stephen S, Park YA, Chrysostomou A.

COVID-19-Associated Collapsing Focal Segmental Glomerulosclerosis: A Report of 2 Cases

Sharma Y, Nasr SH, Larsen CP, Kemper A, Ormsby AH, Williamson SR.

COVID-19-Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis

Magoon S, Bichu P, Malhotra V, Alhashimi F, Hu Y, Khanna S, Berhanu K.

COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium

Devresse A, Belkhir L, Vo B, Ghaye B, Scohy A, Kabamba B, Goffin E, De Greef J, Mourad M, De Meyer M, Yombi JC, Kanaan N.

Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?

Delafosse M, Saint-Jaques C, Petit-Hoang C, François H, Peltier J, Nicolet L, Verney C, Viguier M, Letavernier E, Dahan K.

Epidemiological, Clinical, and Immunological Features of a Cluster of COVID-19-Contracted Hemodialysis Patients

Ma Y, Diao B, Lv X, Zhu J, Chen C, Liu L, Zhang S, Shen B, Wang H.

Dashboards to Facilitate Nephrology Disaster Planning in the COVID-19 Era

Stevens JS, Toma K, Tanzi-Pfeifer S, Rao MK, Mohan S, Gharavi AG, Radhakrishnan J.

Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis

Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, Mohan S.

[Severe acute respiratory syndrome coronavirus 2 infection in renal transplant recipients: A case report]

Li QY, Cheng Q, Zhao ZL, Dai NN, Zeng L, Zhu L, Guo W, Li C, Wang JH, Li S, Ge QG, Shen N.

Awareness and Impact of Non-pharmaceutical Interventions During Coronavirus Disease 2019 Pandemic in Renal Transplant Recipients

Monaco A, Manzia TM, Angelico R, Iaria G, Gazia C, Al Alawi Y, Fourtounas K, Tisone G, Cacciola R.

A family cluster of diagnosed coronavirus disease 2019 (COVID-19) kidney transplant recipient in Thailand

Sakulkonkij P, Bruminhent J, Pankongngam C, Chalermphunchai N.

High mortality of CKD patients on hemodialysis with Covid-19 in Brazil

Pio-Abreu A, do Nascimento MM, Vieira MA, de Menezes Neves PDM, Lugon JR, Sesso R.

Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?

Kow CS, Hasan SS.

Clinical characteristics of patients with uremia undergoing maintenance hemodialysis complicated with COVID-19

Wang Y, Hu M, Ye G, Zhao Y, Yin Q, Pi P, Luo D.

Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors

Vistisen ST, Bodilsen J, Scheeren TWL, Simonsen U.

Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis

Barochiner J, Martínez R.

An increase in kidney transplantation procedures from deceased donors during the COVID-19 epidemic in Slovenia

Arnol M, Smrkolj T, Avsec D, Gadžijev A, Kneževič I.

Vulnerabilities in kidney transplant recipients with COVID-19: a single center experience

Meziyerh S, van der Helm D, de Vries APJ.

Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions

Kienitz T, Hahner S, Burger-Stritt S, Quinkler M.

Acute Kidney Injury Is Associated With In-hospital Mortality in Older Patients With COVID-19

Yan Q, Zuo P, Cheng L, Li Y, Song K, Chen Y, Dai Y, Yang Y, Zhou L, Yu W, Li Y, Xie M, Zhang C, Gao H.

Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank Cases

Raisi-Estabragh Z, McCracken C, Ardissino M, Bethell MS, Cooper J, Cooper C, Harvey NC, Petersen SE.

Increased risk of COVID-19 in haemodialysis healthcare workers in a tertiary centre in the North West of England

Gray S, Clough T, Mcgee Y, Murphy T, Poulikakos D.

Optimising the use of telemedicine in a kidney transplant programme during the coronavirus disease 2019 pandemic

Yadav A, Caldararo K, Singh P.

Impact of the COVID-19 pandemic on clinical research

Tuttle KR.

COVID-19 and the Kidney: From Epidemiology to Clinical Practice

Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M.

Natural language processing for rapid response to emergent diseases: Application to calcium channel blockers therapy in hypertensive patients with COVID-19 infection

Neuraz A, Lerner I, Digan W, Paris N, Tsopra R, Rogier A, Baudoin D, Cohen KB, Burgun A, Garcelon N, Rance B.

Effect of adult COVID-19 surge on the provision of kidney replacement therapy in children

Deep A.

Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy

Ammirati E, Travi G, Orcese C, Sacco A, Auricchio S, Frigerio M, Puoti M.

Characteristics of Renal Function in Patients Diagnosed With COVID-19: An Observational Study

Hong XW, Chi ZP, Liu GY, Huang H, Guo SQ, Fan JR, Lin XW, Qu LZ, Chen RL, Wu LJ, Wang LY, Zhang QC, Wu SW, Pan ZQ, Lin H, Zhou YH, Zhang YH.

COVID-19 Pneumonia: An Emerging Cause of Syndrome of Inappropriate Antidiuretic Hormone

Sheikh MM, Ahmad E, Jeelani HM, Riaz A, Muneeb A.

COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19

Velez JCQ, Caza T, Larsen CP.

Early Report on Published Outcomes in Kidney Transplant Recipients Compared to Nontransplant Patients Infected With Coronavirus Disease 2019

Aziz F, Mandelbrot D, Singh T, Parajuli S, Garg N, Mohamed M, Astor BC, Djamali A.

Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases

Gupta RK, Bhargava R, Shaukat AA, Albert E, Leggat J.

Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy

Ronco C, Reis T, Cozzolino M.

Treatment Impact on COVID-19 evolution in hemodialysis patients

Chawki S, Buchard A, Sakhi H, Dardim K, El Sakhawi K, Chawki M, Boulanger H, Kofman T, Dahmane D, Rieu P, Attaf D, Ahriz-Saksi S, Besson F, Boula R, Hafi A, Massoumi A, Diddaoui AZ, Fromentin L, Michaut P, Nebbad R, Desassis JF, Nicolet L, Ghazali A, Sohier-Attias J, Lamriben L, Adem A, Dupuis E, Rifard MK, Joly D, El Karoui K, Attias P; HD-CovIDF Study group.

The kidney and COVID-19 patients - important considerations

Patel SK, Singh R, Rana J, Tiwari R, Natesan S, Harapan H, Arteaga-Livias K, Bonilla-Aldana DK, Rodríguez-Morales AJ, Dhama K.

[Guidance on the special care of liver or kidney transplant recipients diagnosed with COVID-19]

Remport Á, Gerlei Z, Cseprekál O, Wagner L, Földes K, Marton A, Patonai A, Török S, Haboub-Sandil A, Varga M, Doros A, Smudla A, Fazakas J, Kóbori L.

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection

Salah HM, Calcaterra G, Mehta JL.

Increasing Peritoneal Dialysis Use in Response to the COVID-19 Pandemic: Will It Go Viral?

Brown EA, Perl J.

The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial

Cui H, Wu F, Fan Z, Cheng X, Cheng J, Fan M.

Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection

He Q, Mok TN, Yun L, He C, Li J, Pan J.

Long-term effects of COVID-19 in a patient on maintenance dialysis

Alfano G, Perrone R, Fontana F, Mori G, Lucchi L, Guaraldi G, Magistroni R, Cappelli G; Modena Covid-19 Working Group (MoCo19).

Acute Kidney Injury in the 2019 Novel Coronavirus Disease

Qian JY, Wang B, Liu BC.

Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications

Barillà F, Bassareo PP, Calcaterra G, Romeo F, Mehta JL.

Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients

Shah P, Owens J, Franklin J, Jani Y, Kumar A, Doshi R.

Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: a systematic review and meta-analysis of 40 studies and 25,278 patients

Shao M, Li X, Liu F, Tian T, Luo J, Yang Y.

Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome?

Volpe M, Battistoni A.

Bilateral adrenal hemorrhage in Coronavirus disease 2019 patient: A case report

Frankel M, Feldman I, Levine M, Frank Y, Bogot NR, Benjaminov O, Kurd R, Breuer GS, Munter G.

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Hippisley-Cox J, Young D, Coupland C, Channon KM, Tan PS, Harrison DA, Rowan K, Aveyard P, Pavord ID, Watkinson PJ.

Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2

Gilzad-Kohan H, Jamali F.

Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2

Lee SH, Jee SW, Hwang DY, Kang JK.

Management of Advanced Chronic Kidney Disease During the COVID-19 Pandemic: Suggestions From the Canadian Society of Nephrology COVID-19 Rapid Response Team

White CA, Kappel JE, Levin A, Moran SM, Pandeya S, Thanabalasingam SJ; CSN COVID-19 Rapid Response Team.

High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening

Clarke C, Prendecki M, Dhutia A, Ali MA, Sajjad H, Shivakumar O, Lightstone L, Kelleher P, Pickering MC, Thomas D, Charif R, Griffith M, McAdoo SP, Willicombe M.

Recommendations for the management of the patient with chronic renal disease with SARS-CoV-2

Gómez-Beltrán PA, Domínguez Carranza E, Medero Rubio F, Pérez Márquez M.

[COVID-19: The Perspective Of Nephrology]

Kann M, Benzing T.

COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case Series

Sachdeva M, Uppal NN, Hirsch JS, Ng JH, Malieckal D, Fishbane S, Jhaveri KD; Northwell COVID-19 Research Consortium and the Northwell Nephrology COVID-19 Research Consortium.

Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States

Reddy YNV, Walensky RP, Mendu ML, Green N, Reddy KP.

Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan

Okuhama A, Ishikane M, Katagiri D, Kanda K, Nakamoto T, Kinoshita N, Nunose N, Fukaya T, Kondo I, Katano H, Suzuki T, Ohmagari N, Hinoshita F.

The clinical characteristics and course of COVID-19 in hemodialysis patients

Aydin Bahat K, Parmaksiz E, Sert S.

Authors' Reply: Safety and Efficacy of Bedside Peritoneal Dialysis Catheter Placement in the COVID-19 Era: Initial Experience at a New York City Hospital

Vigiola Cruz M.

CSN COVID-19 Rapid Review Program: Management of Acute Kidney Injury

Clark EG, Hiremath S, Soroka SD, Wald R, Weir MA.

Managing Children With Renal Diseases During the COVID-19 Pandemic

Vasudevan A, Mantan M, Krishnamurthy S, Pais P, Mathew G, Hari P, Kanitkar M, Gulati S, Bagga A, Mishra OP; Indian Society of Pediatric Nephrology.

The Early Days: The Postkidney Transplant Recipients' COVID-19 Journey

Roberts GV, Gee PO.

Postmortem Kidney Pathology Findings in Patients with COVID-19

Santoriello D, Khairallah P, Bomback AS, Xu K, Kudose S, Batal I, Barasch J, Radhakrishnan J, D'Agati V, Markowitz G.

SARS-CoV-2 infection associated acute kidney injury in patients with pre-existing chronic renal disease: A report of two cases

Wang Y, Lv Y, Liu Q.

Possible radiologic renal signs of COVID-19

Basara Akin I, Altay C, Eren Kutsoylu O, Secil M.

COVID-19 and Impending Shortage of Haemodialysis Facilities due to the Rising Incidence of Acute Kidney Injury Requiring Renal Replacement Therapy

Ahmed R, Haseeb A.

COVID-19 and Kidney Disease: Update on Epidemiology, Clinical Manifestations, Pathophysiology and Management

Asgharpour M, Zare E, Mubarak M, Alirezaei A.

Clinical characteristics of 31 hemodialysis patients with 2019 novel coronavirus: a retrospective study

Zhang J, Cao F, Wu SK, Xiang-Heng L, Li W, Li GS, Wang J.

Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)

Cadegiani FA, Goren A, Wambier CG.

Patients' and healthcare personnel expectations for SARS-CoV-2 screening in dialysis unit during the Covid-19 pandemic

Przedlacki J, Wojtaszek E, Żebrowski P, Mieczkowski M, Głogowski T, Pyrża M, Ołdakowska-Jedynak U.

The kidney, COVID-19, and the chemokine network: an intriguing trio

Taverna G, Di Francesco S, Borroni EM, Yiu D, Toniato E, Milanesi S, Chiriva-Internati M, Bresalier RS, Zanoni M, Vota P, Maffei D, Justich M, Grizzi F.

Kidney Replacement Therapy in COVID-19 Induced Kidney Failure and Septic Shock: A Pediatric Continuous Renal Replacement Therapy [PCRRT] Position on Emergency Preparedness With Resource Allocation

Raina R, Chakraborty R, Sethi SK, Bunchman T.

COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression

Angeletti A, Drovandi S, Sanguineri F, Santaniello M, Ferrando G, Forno R, Cipresso G, Caridi G, Riella LV, Cravedi P, Ghiggeri GM.

When the COVID-19 pandemic changed the follow-up landscape of chronic kidney disease: a survey of real-world nephrology practice

Chen G, Zhou Y, Xia J, Yao J, Zheng K, Qin Y, Li X.

A Call for Dialysis-Specific Resource Allocation Guidelines During COVID-19

Parsons JA, Martin DE.

Kidney Stone Care and the COVID-19 Pandemic: Challenges and Opportunities

Hiller SC, Dauw CA, Ghani KR.

COVID-19: a novel menace for the practice of nephrology and how to manage it with minor devastation?

Ulu S, Gungor O, Gok Oguz E, Hasbal NB, Turgut D, Arici M.

Prolonged shedding of SARS-CoV-2 in COVID-19 infected hemodialysis patients

Otsubo S, Aoyama Y, Kinoshita K, Goto T, Otsubo Y, Kamano D, Sumura R, Shinzawa S, Abe T, Noda R, Kobayashi R, Yanagi M, Nitta K, Ishibashi Y.

Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient

Westhoff TH, Seibert FS, Bauer F, Stervbo U, Anft M, Doevelaar AAN, Rohn BJ, Winnekendonk G, Dittmer U, Schenker P, Vonbrunn E, Amann K, Viebahn R, Babel N.

The Impact of COVID-19 on Maintenance Haemodialysis patients: The Indian Scenario

Trivedi M, Shingada A, Shah M, Khanna U, Karnik ND, Ramachandran R.

Acute Kidney Injury in Patients with the Coronavirus Disease 2019: A Multicenter Study

Cui X, Yu X, Wu X, Huang L, Tian Y, Huang X, Zhang Z, Cheng Z, Guo Q, Zhang Y, Cai Y, Zhan Q.

The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future

Zhang J, Wang M, Ding W, Wan J.

Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability-Does One Exist?

Virmani S, Gleeson SE, Girone GF, Malhotra D, Cohen EA, Klarman SE, Asch WS.

A 65-Year-Old Woman with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day History of Dry Cough and Fever Who Presented with Acute Renal Failure Due to Infection with SARS-Cov-2

Sánchez Tinajero Á, González Cueto E, Martínez Orozco JA, Becerril Vargas E, Ruiz Santillán DP, Reséndiz Escobar H.

Impact of COVID-19 on Nephrology Patients: A Mechanistic Outlook for Pathogenesis of Acute Kidney Injury

Saad Alharbi K, Al-Abbasi FA, Prasad Agrawal G, Sharma A, Kowti R, Kazmi I.

Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain

Vila-Corcoles A, Satue-Gracia E, Ochoa-Gondar O, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, Hospital-Guardiola I, de Diego-Cabanes C, Bejarano-Romero F, Rovira-Veciana D, Basora-Gallisa J.

Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019

Siri-Angkul N, Chattipakorn SC, Chattipakorn N.

COVID-19 in children with chronic kidney disease: findings from the UK renal registry

Plumb L, Benoy-Deeney F, Casula A, Braddon FEM, Tse Y, Inward C, Marks S, Steenkamp R, Medcalf J, Nitsch D.

Follow-up and Management of Kidney Transplant Recipients During the COVID-19 Lockdown: The Experience of an Italian Transplant Center, Including Two Cases of COVID-19 Pneumonia

Binda B, Picchi G, Carucci AC, Sinatti G, Di Norcia M, Grimaldi A, Lancione L, Natili A, Chiappori D, Montali F, Lupi D, Martinez V, Panarese A, D'anselmi F, Pisani F.

A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece

Marinaki S, Tsiakas S, Skalioti C, Lourida P, Argyraki A, Grigorakos K, Boletis I.

The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients

Zamai L.

The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients

Stock da Cunha T, Gomá-Garcés E, Avello A, Pereira-García M, Mas-Fontao S, Ortiz A, González-Parra E.

Successful Kidney Transplantation after COVID-19

Varotti G, Dodi F, Garibotto G, Fontana I.

Kidney Transplantation in the Times of COVID-19 - A Literature Review

Imam A, Abukhalaf SA, Imam R, Abu-Gazala S, Merhav H, Khalaileh A.

Protection of nephrology health professionals during the COVID-19 pandemic

Arenas MD, Villar J, Gonz√°lez C, Cao H, Collado S, Barbosa F, Crespo M, Horcajada JP, Pascual J.

Management of peritoneal dialysis under COVID-19: The experience in Sichuan Province People's Hospital, China

Chen J, Yin L, Chen X, Gao H, Zhou Q, Li P, Liu W, Ding H, Hong D, Li G, Wang L.

Management of immunosuppression in kidney transplant recipients with COVID-19 pneumonia: A summary of 41 confirmed cases reported worldwide

Hu Q, Zhong Z, Xiong Y, Ye S, Wang Y, Ye Q.

Kidney Transplant Recipients Infected By COVID-19: Review of the Initial Published Experience

Moris D, Kesseli SJ, Barbas AS.

Continued in-hospital ACE inhibitor and ARB Use in hypertensive COVID-19 patients is associated with positive clinical outcomes

Lam KW, Chow KW, Vo J, Hou W, Li H, Richman PS, Mallipattu SK, Skopicki HA, Singer AJ, Duong TQ.

Protection of Dialysis Staff from COVID-19 Infection: Setting Up and Impact of Extended Blood Lines during Dialysis

Matsuoka R, Masuda T, Akiyama Y, Muto T, Miyamoto Y, Imai T, Kamiyama T, Yokoyama M, Iwamoto S, Sugie S, Ono K, Nagayama I, Kohara-Miura M, Komada T, Suzuki M, Maeshima A, Akimoto T, Saito O, Nagata D.

Influence of Immunosuppression on Seroconversion Against SARS-Cov-2 in Two Kidney Transplant Recipients

Wang AX, Quintero Cardona O, Ho DY, Busque S, Lenihan CR.

Fatal Outcome in a Kidney-Pancreas Transplant Recipient With COVID-19

Suwanwongse K, Shabarek N.

Coronavirus disease 2019 in chronic kidney disease

D'Marco L, Puchades MJ, Romero-Parra M, Gimenez-Civera E, Soler MJ, Ortiz A, Gorriz JL.

Kidney disease and electrolytes in COVID-19: more than meets the eye

Carriazo S, Kanbay M, Ortiz A.

Peritoneal dialysis in the time of coronavirus disease 2019

Alfano G, Fontana F, Ferrari A, Guaraldi G, Mussini C, Magistroni R, Cappelli G; Modena Covid-19 Working Group (MoCo19).

The Importance of COVID-19 Prevention and Containment in Hemodialysis Unit

Lim MA, Pranata R.

COVID-19 and hypertensive disease in Brazil: possibility of a perfect storm

Melo DO, Ribeiro TB, Grezzana GB, Stein AT.

Chronic kidney disease and SARS-CoV-2 outbreak: Lazio region organizational model

Dominijanni S, Foniciello M, Tatangelo P, Angeloni V, Londrino F, Daniele ND, Grandaliano G, Morosetti M, Palumbo R.

Silent COVID-19 in haemodialysis facilities in Cantabria, Spain: an ecological study

Rodrigo E, Piñera VC, Setién MA, Siller M, Pablo D, Tejido R, Ruiz JC.

The syndrome of inappropriate antidiuresis in COVID-19 pneumonia: report of two cases

Ravioli S, Niebuhr N, Ruchti C, Pluess E, Stoeckli T, Lindner G.

Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury

Kormann R, Jacquot A, Alla A, Corbel A, Koszutski M, Voirin P, Garcia Parrilla M, Bevilacqua S, Schvoerer E, Gueant JL, Namour F, Levy B, Frimat L, Oussalah A.

Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019

Rubin S, Orieux A, Prevel R, Garric A, Bats ML, Dabernat S, Camou F, Guisset O, Issa N, Mourissoux G, Dewitte A, Joannes-Boyau O, Fleureau C, Rozé H, Carrié C, Petit L, Clouzeau B, Sazio C, Bui HN, Pillet O, Rigothier C, Vargas F, Combe C, Gruson D, Boyer A.

Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients

Couturier A, Ferlicot S, Chevalier K, Guillet M, Essig M, Jauréguiberry S, Collarino R, Dargelos M, Michaut A, Geri G, Roque-Afonso AM, Zaidan M, Massy ZA.

Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study

Hong D, Long L, Wang AY, Lei Y, Tang Y, Zhao JW, Song X, He Y, Wen E, Zheng L, Li G, Wang L.

SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience

Fontana F, Giaroni F, Frisina M, Alfano G, Mori G, Lucchi L, Magistroni R, Cappelli G.

Clinical outcomes of hemodialysis patients infected with severe acute respiratory syndrome coronavirus 2 and impact of proactive chest computed tomography scans

Wang R, He H, Liao C, Hu H, Hu C, Zhang J, Gao P, Wu X, Cheng Z, Liao M, Shui H.

Operational considerations for peritoneal dialysis management during the COVID-19 pandemic

Yang Z, Dong J.

A brand-new cardiorenal syndrome in the COVID-19  setting

Apetrii M, Enache S, Siriopol D, Burlacu A, Kanbay A, Kanbay M, Scripcariu D, Covic A.

Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury

Ponce D, Balbi AL, Durand JB, Moretta G, Divino-Filho JC.

Increased mortality among hypertensive COVID-19 patients: Pay a closer look on diuretics in mechanically ventilated patients

Tsolaki V, Zakynthinos GE, Mantzarlis K, Makris D.

Coronavirus Disease 2019: Coronaviruses and Kidney Injury

Lv W, Wu M, Ren Y, Zeng N, Deng P, Zeng H, Zhang Q, Wu Y.

Co-infection with SARS-CoV-2 and parainfluenza virus in a hemodialysis patient: A case report‚Ä©

He H, Liao C, Wang R, Wu T, Zhang J, Hu C, Shui H.

COVID-19 and the kidney: what we think we know so far and what we don't

Farouk SS, Fiaccadori E, Cravedi P, Campbell KN.

Uneventful case of COVID-19 in a kidney transplant recipient

Dahl Mathiasen V, Jensen-Fangel S, Skov K, Leth S.

The care of kidney transplant recipients during a global pandemic: Challenges and strategies for success

Aziz F, Jorgenson MR, Garg N, Mohamed M, Djamali A, Mandelbrot D, Parajuli S.

Progressive renal impairment in an older patient with 2019 coronavirus disease (COVID-19): a case report and literature review

Zhu D, Xu J, Chen H, Wang S, Yu L.

Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients

Holt A, Mizrak I, Lamberts M, Lav Madsen P.

Acute Kidney Injury and Kidney Damage in COVID-19 Patients

Na KR, Kim HR, Ham Y, Choi DE, Lee KW, Moon JY, Kim YS, Cheon S, Sohn KM, Kim J, Kim S, Jeong H, Jeon JW.

The Dilemma of Renal Involvement in COVID-19: A Systematic Review

Bajwa H, Riaz Y, Ammar M, Farooq S, Yousaf A.

Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade

Chenna A, Konala VM, Bose S, Roy S, Madhira BR, Gayam V, Naramala S, Adapa S.

Multiorgan Failure With Emphasis on Acute Kidney Injury and Severity of COVID-19: Systematic Review and Meta-Analysis

Lim MA, Pranata R, Huang I, Yonas E, Soeroto AY, Supriyadi R.

COVID-19 pneumonia presenting as a single pulmonary nodule in a kidney transplant recipient: A case report and literature review

Rasekhi A, Hoseinyazdi M, Esmaeilian S, Teimouri A, Safaei A, Rafiee F.

Case Report: COVID-19 with Bilateral Adrenal Hemorrhage

Álvarez-Troncoso J, Zapatero Larrauri M, Montero Vega MD, Gil Vallano R, Palmier Peláez E, Martín Rojas-Marcos P, Martín-Luengo F, Lázaro Del Campo P, Herrero Gil CR, Trigo Esteban E.

COVID-19 Outbreak in an Urban Hemodialysis Unit

Yau K, Muller MP, Lin M, Siddiqui N, Neskovic S, Shokar G, Fattouh R, Matukas LM, Beaubien-Souligny W, Thomas A, Weinstein JJ, Zaltzman J, Wald R.

Clinical Characteristics and Outcome of Covid-19 Pneumonia in kidney Transplant Recipients in Razi hospital, Rasht, Iran

Monfared A, Dashti-Khavidaki S, Jafari R, Jafari A, Ramezanzade E, Lebadi MK, Haghdar-Saheli Y, Aghajanzadeh P, Khosravi M, Movassaghi A, Taghvaye-Masoumi H, Alavi Foumani A.

Kidney Transplantation during Coronavirus 2019 Pandemic at a Large Hospital in Miami

Chandorkar A, Coro A, Natori Y, Anjan S, Abbo LM, Guerra G, Mattiazzi AD, Mendez-Castaner LA, Morris MI, Camargo JF, Vianna R, Simkins J.

SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production

Franco R, Rivas-Santisteban R, Serrano-Marín J, Rodríguez-Pérez AI, Labandeira-García JL, Navarro G.

Kidney Biopsy Findings in Patients with COVID-19

Kudose S, Batal I, Santoriello D, Xu K, Barasch J, Peleg Y, Canetta P, Ratner LE, Marasa M, Gharavi AG, Stokes MB, Markowitz GS, D'Agati VD.

Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?

Vitiello A, Ferrara F.

Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center

Lubetzky M, Aull MJ, Craig-Schapiro R, Lee JR, Marku-Podvorica J, Salinas T, Gingras L, Lee JB, Sultan S, Kodiyanplakkal RP, Hartono C, Saal S, Muthukumar T, Kapur S, Suthanthiran M, Dadhania DM.

Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis

Chen YT, Shao SC, Lai EC, Hung MJ, Chen YC.

COVID-19 and Kidney Transplant Recipients

Abolghasemi S, Mardani M, Sali S, Honarvar N, Baziboroun M.

The advantages of peritoneal dialysis over hemodialysis during the COVID-19 pandemic

Chen TH, Wen YH, Chen CF, Tan AC, Chen YT, Chen FY, Lin CC.

Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study

Dublin S, Walker RL, Floyd JS, Shortreed SM, Fuller S, Albertson-Junkans LH, Harrington LB, Greenwood-Hickman MA, Green BB, Psaty BM.

Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19

Golmai P, Larsen CP, DeVita MV, Wahl SJ, Weins A, Rennke HG, Bijol V, Rosenstock JL.

The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents

De Spiegeleer A, Bronselaer A, Teo JT, Byttebier G, De Tré G, Belmans L, Dobson R, Wynendaele E, Van De Wiele C, Vandaele F, Van Dijck D, Bean D, Fedson D, De Spiegeleer B.

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?

Bloch MJ.

Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19

Wu C, Ye D, Mullick AE, Li Z, Danser AHJ, Daugherty A, Lu HS.

SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease

Cancarevic I, Malik BH.

Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19

Wysocki J, Lores E, Ye M, Soler MJ, Batlle D.

AKI in Hospitalized Patients with and without COVID-19: A Comparison Study

Fisher M, Neugarten J, Bellin E, Yunes M, Stahl L, Johns TS, Abramowitz MK, Levy R, Kumar N, Mokrzycki MH, Coco M, Dominguez M, Prudhvi K, Golestaneh L.

Rationing Scarce Resources: The Potential Impact of COVID-19 on Patients with Chronic Kidney Disease

Silberzweig J, Ikizler TA, Kramer H, Palevsky PM, Vassalotti J, Kliger AS.

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma

Aeppli S, Eboulet EI, Eisen T, Escudier B, Fischer S, Larkin J, Gruenwald V, McDermott D, Oldenburg J, Omlin A, Porta C, Rini B, Schmidinger M, Sternberg C, Rothermundt C.

COVID-19-Related Collapsing Glomerulopathy in a Kidney Transplant Recipient

Lazareth H, Péré H, Binois Y, Chabannes M, Schurder J, Bruneau T, Karras A, Thervet E, Rabant M, Veyer D, Pallet N.

Acute Kidney Injury by SARS-CoV-2 virus in patients with COVID-19: an integrative review

Moitinho MS, Belasco AGDS, Barbosa DA, Fonseca CDD.

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19

Bosso M, Thanaraj TA, Abu-Farha M, Alanbaei M, Abubaker J, Al-Mulla F.

COVID-19 Outbreak and Management Approach for Families with Children on Long-Term Kidney Replacement Therapy

Zhao R, Zhou Q, Wang XW, Liu CH, Wang M, Yang Q, Zhai YH, Zhu DQ, Chen J, Fang XY, Tang XS, Zhang H, Shen Q, Xu H.

Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care

Deep A, Bansal M, Ricci Z.

Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review

Zaki N, Alashwal H, Ibrahim S.

Covid-19, ACE2, and the kidney

Hardenberg JH, Luft FC.

COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings

Sharma P, Uppal NN, Wanchoo R, Shah HH, Yang Y, Parikh R, Khanin Y, Madireddy V, Larsen CP, Jhaveri KD, Bijol V; Northwell Nephrology COVID-19 Research Consortium.

COVID-19, Racism, and Racial Disparities in Kidney Disease: Galvanizing the Kidney Community Response

Crews DC, Purnell TS.

COVID-19, Renin-Angiotensin System and Endothelial Dysfunction

Amraei R, Rahimi N.

Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy

Fominskiy EV, Scandroglio AM, Monti G, Calabrò MG, Landoni G, Dell'Acqua A, Beretta L, Moizo E, Ravizza A, Monaco F, Campochiaro C, Pieri M, Azzolini ML, Borghi G, Crivellari M, Conte C, Mattioli C, Silvani P, Mucci M, Turi S, Tentori S, Baiardo Redaelli M, Sartorelli M, Angelillo P, Belletti A, Nardelli P, Nisi FG, Valsecchi G, Barberio C, Ciceri F, Serpa Neto A, Dagna L, Bellomo R, Zangrillo A; COVID-BioB Study Group.

[Remote patient monitoring in dialysis patients: the "change of pace" for home dialysis.]

Borrelli S, Frattolillo V, Garofalo C, Provenzano M, Genualdo R, Conte G, Minutolo R, De Nicola L.

[COVID-19 and kidney disease]

Smolander J, Bruchfeld A.

COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul

Demir E, Uyar M, Parmaksiz E, Sinangil A, Yelken B, Dirim AB, Merhametsiz O, Yadigar S, Atan Ucar Z, Ucar AR, Demir ME, Mese M, Akin EB, Garayeva N, Safak S, Oto OA, Yazici H, Turkmen A.

Angiotensin-Converting Enzyme 2 as a Versatile Player in the Management of Coronavirus Disease 2019

Amano T.

Covid-19 in kidney transplant recipients: a systematic review of the case series available three months into the pandemic

Oltean M, S√∏fteland JM, Bagge J, Ekelund J, Felldin M, Schult A, Magnusson J, Friman V, Karason K.

COVID-19 pandemic in limited-resource countries: Strategies for challenges in a dialysis unit

Bharati J, Ramachandran R, Kumar V, Kohli HS.

Risk-prediction model for COVID-19 infection in dialysis patients

Yasri S, Wiwanitkit V.

Response to Comment on; Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report

Moradi H, Naimi A, Moeinzadeh F.

Comment: Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report

Mubarak M, Tolouian R, Kowalewska J, Nasri H.

Surveillance and Isolation Based Strategies to Prevent COVID-19 in a Dialysis Center of Tehran, a Customized Approach

Najafi MT, Abbasi MR, Dehghan Manshadi SA, Rahimzadeh S, Shojamoradi MH.

Clinical and Radiologic Characteristics of COVID-19 in Patients With CKD

Abrishami A, Khalili N, Dalili N, Khaleghnejad Tabari R, Farjad R, Samavat S, Neyriz Naghadehi A, Haghighatkhah H, Nafar M, Sanei-Taheri M.

Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review

Dashti-Khavidaki S, Khalili H, Nourian A.

Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis

Hansrivijit P, Qian C, Boonpheng B, Thongprayoon C, Vallabhajosyula S, Cheungpasitporn W, Ghahramani N.

Does "Flattening the Curve" Affect Critical Care Services Delivery for COVID-19? A Global Health Perspective

Gilardino RE.

Use of tocilizumab in kidney transplant recipients with COVID-19

Pérez-Sáez MJ, Blasco M, Redondo-Pachón D, Ventura Aguilar P, Bada-Bosch T, Pérez-Flores I, Melilli E, Sánchez-Cámara LA, López-Oliva MO, Canal C, Shabaka A, Garra Moncau N, Martín-Moreno PL, López V, Hernández-Gallego R, Siverio O, Galeano C, Espí Reig J, Cabezas CJ, Rodrigo MT, Llinàs-Mallol L, Fernández-Reyes MJ, Cruzado Vega L, Pérez-Tamajón L, Santana-Estupiñán R, Ruiz-Fuentes MC, Tabernero G, Zárraga S, Carlos Ruiz J, Gutiérrez-Dalmau A, Mazuecos A, Sánchez-Álvarez E,

Low Rate of COVID-19 pneumonia in Kidney Transplant Recipients - A Battle Between Infection and Immune Response?

Ghaffari Rahbar M, Nafar M, Khoshdel A, Dalili N, Abrishami A, Firouzan A, Poorrezagholi F, Samadian F, Ziaie S, Fatemizadeh S, Samavat S.

Kidney transplant in the COVID era: Cautious optimism and continued vigilance

McElroy L, Sanoff S, Collins B.

Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities

Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C.

Syndrome of inappropriate antidiuretic hormone as the initial presentation of COVID-19: A novel case report

Ho KS, Narasimhan B, Kumar A, Flynn E, Salonia J, El-Hachem K, Mathew JP.

Caution in Identifying Coronaviruses by Electron Microscopy

Goldsmith CS, Miller SE.

Is the immune hyporesponsiveness of uremic patients a protective factor for severe COVID-19 pneumonia?

Florit EA, Diekmann F.

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors

Golpe R, Pérez-de-Llano LA, Dacal D, Guerrero-Sande H, Pombo-Vide B, Ventura-Valcárcel P; Lugo Covid-19 team.

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19

Gade AR, Alavala H, Allam SR.

COVID-19 and Kidney Transplantation: Results from the TANGO International Transplant Consortium

Cravedi P, Suraj SM, Azzi Y, Haverly M, Farouk S, Pérez-Sáez MJ, Redondo-Pachón MD, Murphy B, Florman S, Cyrino LG, Grafals M, Venkataraman S, Cheng XS, Wang AX, Zaza G, Ranghino A, Furian L, Manrique J, Maggiore U, Gandolfini I, Agrawal N, Patel H, Akalin E, Riella LV; TANGO study group.

Letter to the Editor: Safety and Efficacy of Bedside Peritoneal Dialysis Catheter Placement in the COVID-19 Era: Initial Experience at a New York City Hospital

Ch√°vez Valencia V, Lagunas Rangel FA, Orizaga de la Cruz C.

Kidney Involvement in COVID-19: Need for Better Definitions

Delsante M, Rossi GM, Gandolfini I, Bagnasco SM, Rosenberg AZ.

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?

Bendjelid K.

Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience

Heinicke U, Adam E, Sonntagbauer M, von Knethen A, Zacharowski K, Neb H.

Angiotensin II Receptors - Impact for COVID-19 Severity

Aksoy H, Karadag AS, Wollina U.

Rhabdomyolysis and Acute Renal Failure in an Adolescent with COVID-19

Samies NL, Pinninti S, James SH.

Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19 in critically ill elderly patients

Jung C, Bruno RR, Wernly B, Joannidis M, Oeyen S, Zafeiridis T, Marsh B, Andersen FH, Moreno R, Fernandes AM, Artigas A, Pinto BB, Schefold J, Wolff G, Kelm M, De Lange DW, Guidet B, Flaatten H, Fj√∏lner J; COVIP study group.

COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network

Kario K, Morisawa Y, Sukonthasarn A, Turana Y, Chia YC, Park S, Wang TD, Chen CH, Tay JC, Li Y, Wang JG; Hypertension Cardiovascular Outcome Prevention, Evidence in Asia (HOPE Asia) Network.

Renal complications in COVID-19: A systematic review and meta-analysis

Kunutsor SK, Laukkanen JA.

COVID-19 Outbreak in a Large Hemodialysis Center in Lombardy, Italy

La Milia V, Bacchini G, Bigi MC, Casartelli D, Cavalli A, Corti M, Crepaldi M, Limardo M, Longhi S, Manzoni C, Ravasi C, Stucchi V, Viganò S.

Delivering Dialysis During the COVID-19 Outbreak: Strategies and Outcomes

Roper T, Kumar N, Lewis-Morris T, Moxham V, Kassimatis T, Game D, Breen C, Moutzouris DA.

Preparedness of Kidney Replacement Therapy in the Critically Ill During COVID-19 Surge

Neyra JA, Connor MJ Jr, Tolwani A.

Acute Renal Failure in Critically Ill COVID-19 Patients With a Focus on the Role of Renal Replacement Therapy: A Review of What We Know So Far

Raza A, Estepa A, Chan V, Jafar MS.

Suspension and resumption of kidney transplant programs during the COVID-19 pandemic: perspectives from patients, caregivers and potential living donors-a qualitative study

Guha C, Tong A, Baumgart A, Scholes-Robertson N, Isbel N, Kanellis J, Campbell S, Coates T, Chadban S.

Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury

Kow CS, Hasan SS.

DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY

Sarzani R, Giulietti F, Di Pentima C, Giordano P, Spannella F.

COVID-19 Pandemic - Nephrology Experiences

Prevention and Control of COVID-19 in Chronic Kidney Disease: Correspondence

Kalra S.

Authors' Reply

Batlle D, Soler MJ, Welling PA, Swaminathan S; COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group*.

COVID-19 in Patients with Kidney Disease

Ajaimy M, Melamed ML.

NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection

Cumhur Cure M, Kucuk A, Cure E.

Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19

Gue YX, Kanji R, Markides V, Gorog DA.

Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy

Sardu C, Maggi P, Messina V, Iuliano P, Sardu A, Iovinella V, Paolisso G, Marfella R.

Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic

Dworakowska D, Grossman AB.

Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report

Huang L, Wang Y, Wang L, Lv Y, Liu Q.

Serologic Detection of Latent SARS-CoV-2 Infections in Hemodialysis Centers: A Multi-center, Retrospective Study in Wuhan, China

Tang H, Tian JB, Dong JW, Tang XT, Yan ZY, Zhao YY, Xiong F, Sun X, Song CX, Xiang CG, Tu C, Lei CT, Liu J, Su H, Huang J, Qiu Y, Miao XP, Zhang C.

Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?

Eroğlu I, Çelik Eroğlu B, Uyaroğlu OA, Sain Güven G.

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19

Şenkal N, Meral R, Medetalibeyoğlu A, Konyaoğlu H, Kose M, Tukek T.

Renin-angiotensin system inhibition in COVID-19 patients: Friend or foe?

Karadağ B.

Kidney transplant patients with SARS-CoV-2 infection: the brescia renal COVID task force experience

Bossini N, Alberici F, Delbarba E, Valerio F, Manenti C, Possenti S, Econimo L, Maffei C, Pola A, Terlizzi V, Salviani C, Moscato M, Pasquali S, Zambetti N, Tonoli M, Affatato S, Pecchini P, Battista Viola F, Malberti F, Depetri G, Gaggiotti M, Scolari F; Brescia Renal COVID task force.

Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice

Guo LP, Liu SX, Yang Q, Liu HY, Xu LL, Hao YH, Zhang XQ.

ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?

Pagliaro P, Penna C.

Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS

Gumashta J, Gumashta R.

COVID-19-related Mortality During the First 60 Days After Kidney Transplantation

Pascual J, Melilli E, Jiménez-Martín C, González-Monte E, Zárraga S, Gutiérrez-Dalmau A, López-Jiménez V, Juega J, Muñoz-Cepeda M, Lorenzo I, Facundo C, Ruiz-Fuentes MDC, Mazuecos A, Sánchez-Álvarez E, Crespo M; Spanish Society of Nephrology COVID-19 Group.

A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19

Usman MS, Siddiqi TJ, Khan MS, Ahmed A, Ali SS, Michos ED, Hall ME, Krasuski RA, Greene SJ, Butler J, Alkhouli M.

Long-Term ACE Inhibitor/ARB Use Is Associated with Severe Renal Dysfunction and Acute Kidney Injury in Patients with severe COVID-19: Results from a Referral Center Cohort in the North East of France

Oussalah A, Gleye S, Clerc Urmes I, Laugel E, Callet J, Barbé F, Orlowski S, Malaplate C, Aimone-Gastin I, Caillierez BM, Merten M, Jeannesson E, Kormann R, Olivier JL, Rodriguez-Guéant RM, Namour F, Bevilacqua S, Losser MR, Levy B, Kimmoun A, Gibot S, Thilly N, Frimat L, Schvoerer E, Guéant JL.

Role of expanded hemodialysis in COVID-19: a case report

Valga F, Vega-Díaz N, Monzón T, González-Cabrera F, Santana A, Baamonde E, Gallego R, Quevedo-Reina JC, Rodríguez-Pérez JC.

Results of a healthcare organization model for COVID-19 on hemodialysis in a tertiary hospital and its subsidized centers

Sánchez-Pérez P, González-Calero P, Poma-Saavedra FH, Orero-Calvé E, Devesa-Such R, Soldevila-Orient A, Henningsmeyer-Utrera B, Lacueva-Moya J.

Time to Expand Access and Utilization of Home Dialysis: Lessons From the COVID-19 Pandemic

Stern LD, Waikar S.

ACE inhibitors/ARB use and COVID-19. Time to change practice or keep gathering data?

de Feria A, Ortega-Legaspi JM.

The clinical course and short-term outcome of COVID-19 in a cohort of hemodialysis patients

Petrulewicz A, Rydzewska-Rosołowska A, Fiderkiewicz B, Wasińska-Krawczyk A, Brzósko S, Walecki J, Rydzewski A.

GOING TO WAR ON COVID19: MOBILIZING AN ACADEMIC NEPHROLOGY GROUP PRACTICE

Lee MB, Chua HR, Wong WK, Chan GC, Leo CCH, Vathsala A, Teo BW.

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

Xu J, Huang C, Fan G, Liu Z, Shang L, Zhou F, Wang Y, Yu J, Yang L, Xie K, Huang Z, Huang L, Gu X, Li H, Zhang Y, Wang Y, Hayden FG, Horby PW, Cao B, Wang C.

Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology

Quintaliani G, Reboldi G, Di Napoli A, Nordio M, Limido A, Aucella F, Messa P, Brunori G; Italian Society of Nephrology COVID-19 Research Group.

Long-Term Hemodialysis during the COVID-19 Pandemic

Gedney N.

Acute Kidney Injury in Coronavirus Disease 2019 Infected Patients: A Meta-Analytic Study

Brienza N, Puntillo F, Romagnoli S, Tritapepe L.

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Pranata R, Permana H, Huang I, Lim MA, Soetedjo NNM, Supriyadi R, Soeroto AY, Alkatiri AA, Firman D, Lukito AA.

Care of Asymptomatic SARS-CoV-2 positive Kidney Transplant Recipients

Velioglu A, Tuglular S.

Atypical Presentation of COVID-19: Acute Renal Failure

Kerget B, Akgun M, Dogan N.

Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis

Flacco ME, Acuti Martellucci C, Bravi F, Parruti G, Cappadona R, Mascitelli A, Manfredini R, Mantovani LG, Manzoli L.

Pathological Role of Angiotensin II in Severe COVID-19

Miesbach W.

Evaluating Potential Deceased Donor Renal Transplant Recipients for Asymptomatic COVID-19

Ho QY, Chung SJ, Low SCS, Chen RC, Teh SP, Chan FZY, Tan BH, Kee TYS.

In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'

De Vriese AS, Reynders M.

Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?

Dudreuilh C, Moutzouris DA.

Belatacept, kidney transplantation and COVID-19: successful management of the first reported case within the United Kingdom

Hasan Ahmad S, Smith R, Camilleri B.

Convalescent Plasma Therapy: Helpful Treatment of COVID-19 in a Kidney Transplant Recipient presenting with serve clinical manifestation and complex complications

Jiang J, Miao Y, Zhao Y, Lu X, Zhou P, Zhou X, Chen Z, Du D.

Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection

Tan HW, Xu YM, Lau ATY.

Coronavirus Disease (COVID-19) hospitalized patients with acute kidney injury (AKI) treated with acute peritoneal dialysis do not have infectious PD effluent

El Shamy O, Vassalotti JA, Sharma S, Aydillo-Gomez T, Marjanovic N, Ramos I, García-Sastre A, Uribarri J.

Relationship Between ACE2 and Other Components of the Renin-Angiotensin System

Cohen JB, Hanff TC, Bress AP, South AM.

Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient

Kadosh BS, Pavone J, Wu M, Reyentovich A, Gidea C.

Role of pediatric nephrologists in managing adults with AKI due to COVID-19

Lipton M, Kavanagh CR, Mahajan R, Jain NG, Uy NS, Dogra S, Lin F.

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study

Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte Salles T, Fernandez Bertolin S, Aragon M, DuVall SL, Lynch K, Falconer T, van Bochove K, Sung C, Matheny ME, Lambert CG, Nyberg F, AlShammari TM, Williams AE, Park RW, Weaver J, Sena AG, Schuemie MJ, Rijnbeek PR, Williams RD, Lane JCE, Prats Uribe A, Zhang L, Areia C, Krumholz H, Prieto Alhambra D, Ryan PB, Hripcsak G, Suchard MA.

Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19

Wu C, Ye D, Mullick AE, Li Z, Danser AHJ, Daugherty A, Lu HS.

COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients With Chronic Kidney Disease and Renal Transplantation

Adapa S, Chenna A, Balla M, Merugu GP, Koduri NM, Daggubati SR, Gayam V, Naramala S, Konala VM.

Managing the dialysis mode for people infected with COVID-19

Wei L, Wang J, Mei Z, Xiang-Heng L, Li GS, Dong JW, Zhang J.

Re: Covid-19 and Kidney Transplantation

Goldfarb DA.

A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient

Thammathiwat T, Tungsanga S, Tiankanon K, Torvorapanit P, Chumpangern W, Udomkarnjananun S, Avihingsanon Y, Sriprasart T, Srisawat N, Jutivorakool K, Paitoonpong L, Putcharoen O, Townamchai N.

Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak

So H, Szeto CC, Tam LS.

Telemedicine holds many promises but needs to be developed to be accepted by patients as an alternative to a visit to the doctor. Response to: 'Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak' by So et al

Schulze-Koops H, Specker C, Krueger K.

Adrenal Vascular Changes in COVID-19 Autopsies

Iuga AC, Marboe CC, Yilmaz MM, Lefkowitch JH, Gauran C, Lagana SM.

Outpatient Management of Kidney Transplant Recipients with Suspected COVID-19- Single Center Experience during the New York City Surge

Mehta SA, Leonard J, Labella P, Cartiera K, Soomro I, Neumann H, Montgomery RA, Ali NM.

Decreased plasma levels of the survival factor renalase are associated with worse outcomes in COVID-19

Wang M, Guo X, Chun HJ, Lee AI, Cha C, Gorelick F, Desir GV.

[Application of continuous renal replacement therapy in coronavirus disease 2019]

Liu J, Zhou Y, Wang M, Liu Y, Du H, Wang T, Zhang L, Chen Y, Chen D.

Association between angiotensin blockade and COVID-19 severity in Hong Kong

Cheung KS, Hung IFN, Leung WK.

Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19

Quinn KL, Fralick M, Zipursky JS, Stall NM.

The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials

Lumbers ER, Delforce SJ, Pringle KG, Smith GR.

SARS-CoV-2 infection in kidney transplant recipients: experience of the italian marche region

Maritati F, Cerutti E, Zuccatosta L, Fiorentini A, Finale C, Ficosecco M, Cristiano F, Capestro A, Balestra E, Taruscia D, Vivarelli M, Donati A, Perna GP, Giacometti A, Tavio M, Onesta M, Di Sante L, Ranghino A.

COVID-19 Pneumonia in Kidney Transplant Recipients: Focus on Immunosuppression Management

Chen TY, Farghaly S, Cham S, Tatem LL, Sin JH, Rauda R, Ribisi M, Sumrani N.

Unusually High Rates of Acute Rejection During the COVID-19 Pandemic: Cause for Concern?

Aziz F, Muth B, Parajuli S, Garg N, Mohamed M, Mandelbrot D, Djamali A.

Kidney transplantation trends in South Korea during the COVID-19 pandemic

Lee J, Huh KH.

Activation of the Renin-angiotensin-aldosterone system is associated with Acute Kidney injury in COVID-19

Dudoignon E, Moreno N, Deniau B, Coutrot M, Longer R, Amiot Q, Mebazaa A, Pirracchio R, Depret F, Legrand M.

COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack?

Arnold RH.

Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2

Ji H, de Souza AMA, Bajaj B, Zheng W, Wu X, Speth RC, Sandberg K.

Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension

Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M; SARS-RAS Investigator.

Fatal SARS-CoV-2 infection in a renal transplant recipient

Dirim AB, Demir E, Ucar AR, Garayeva N, Safak S, Oto OA, Yazici H, Alibeyoglu AM, Orhun G, Cagatay AA, Turkmen A.

Haddon Matrix for Kidney Transplantation during COVID-19 Pandemic: A Problem Solving Framework for Present and Future

Tantisattamo E, Ferrey AJ, Reddy UG, Ichii H, Dafoe DC, Kalantar-Zadeh K.

Challenges in COVID-19 medical response: a nephrology perspective

Betonico GN, Lima EQ, Tome ACN.

COVID-19 and the RAAS

Naik GOA.

Mental health of health-care workers in the COVID-19 era

Greenberg N.

AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype

Wu H, Larsen CP, Hernandez-Arroyo CF, Mohamed MMB, Caza T, Sharshir M, Chughtai A, Xie L, Gimenez JM, Sandow TA, Lusco MA, Yang H, Acheampong E, Rosales IA, Colvin RB, Fogo AB, Velez JCQ.

Epidemiology of COVID-19 in an Urban Dialysis Center

Corbett RW, Blakey S, Nitsch D, Loucaidou M, McLean A, Duncan N, Ashby DR; West London Renal and Transplant Centre.

Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19

Sánchez Cadena AD, Negreira Caamaño M, Pérez Serrano R, Porras Leal ML.

COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status

Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, Hudson KE, Zimring JC, Hansen KC, Hod EA, Spitalnik SL, D'Alessandro A.

Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19

Curfman G.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

Fosbøl EL, Butt JH, Østergaard L, Andersson C, Selmer C, Kragholm K, Schou M, Phelps M, Gislason GH, Gerds TA, Torp-Pedersen C, Køber L.

The first case of COVID-19 pneumonia in a hemodialysis patient in Japan

Kuroki Y, Hiyama K, Minami J, Takeuchi M, Shojima M, Matsueda S, Nagae H, Nakano T.

The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications

Diamond B.

Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic

Almeida MQ, Mendonca BB.

Clinical Characteristics and Outcomes of Community- and Hospital-Acquired Acute Kidney Injury with COVID-19 in a US Inner City Hospital System

Pelayo J, Lo KB, Bhargav R, Gul F, Peterson E, DeJoy Iii R, Salacup GF, Albano J, Gopalakrishnan A, Azmaiparashvili Z, Patarroyo-Aponte G, Rangaswami J.

Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug

Benítez-Cardoza CG, Vique-Sánchez JL.

Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?

Giollo A, Cioffi G, Rossini M, Viapiana O, De Simone G.

Drugs acting on renin angiotensin system and use in ill patients with COVID-19

Alexandre J, Cracowski JL, Richard V, Bouhanick B; French Society of Pharmacology and Therapeutics (SFPT).

Renal dysfunction in hospitalised children with COVID-19

Stewart DJ, Hartley JC, Johnson M, Marks SD, du Pré P, Stojanovic J.

Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis

Yang X, Jin Y, Li R, Zhang Z, Sun R, Chen D.

Acute peritoneal dialysis in COVID-19

Parapiboon W, Ponce D, Cullis B.

Early experience with COVID-19 in kidney transplantation recipients: update and review

González J, Ciancio G.

Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?

Vikse J, Lippi G, Henry BM.

Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic

Zequi SC, Abreu D.

Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19?

Aamodt AH, Bj√∏rk MH, Tronvik EA, Buanes EA, Stovner LJ, Atar D.

Management of hypertension in COVID-19

Antwi-Amoabeng D, Beutler BD, Moody AE, Kanji Z, Gullapalli N, Rowan CJ.

Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19

Han YL, Li YM, Ma CS.

Acute Start Peritoneal Dialysis during the COVID-19 Pandemic: Outcomes and Experiences

El Shamy O, Patel N, Abdelbaset MH, Chenet L, Tokita J, Lookstein R, Lee DS, Cohen NA, Sharma S, Uribarri J.

Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis

Chen YT, Shao SC, Hsu CK, Wu IW, Hung MJ, Chen YC.

Should We Perform Old-for-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay

Zeuschner P, Sester U, Stöckle M, Saar M, Zompolas I, El-Bandar N, Liefeldt L, Budde K, Öllinger R, Ritschl P, Schlomm T, Mihm J, Friedersdorff F.

"SARS-CoV-2 in the peritoneal waste of patients treated with peritoneal dialysis"

Candellier A, Goffin É.

The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?

Cozzolino M, Piccoli GB, Ikizler TA, Ronco C.

A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers

Grover A, Oberoi M.

Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: A case report

Chen D, Yang B, Zhang Y, Chen L, Wei L, Zhang W, Wang X, Tong X, Chen Z.

Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19

Maldonado V, Loza-Mejía MA, Chávez-Alderete J.

COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer

Mihalopoulos M, Dogra N, Mohamed N, Badani K, Kyprianou N.

[Renal transplantation during COVID-19 period in Spain.]

Ponce Díaz-Reixa JL, Domínguez Gil B, Coll E, Musquera M, García E, Cabello R, León E, Parra L, Cuevas Á, Antón B, Campos J.

Renal cell carcinoma and COVID-19 pandemia: Management strategies adapted to current practice

Hevia V, Linares-Espinós E, Alonso-Gordoa T, Fernández-Pello S, Guerrero-Ramos F, Mir C, Molina-Cerrillo J, Musquera-Felip M, Rodríguez-Faba Ó, de Velasco G, Gómez-Dos Santos V.

Bone Infections, Sinusitis, Antihypertensive Therapy and COVID-19, Toilet Training, Amenorrhea

EPO in Patients With COVID-19: More Than an Erythropoietic Hormone

Leventhal J, Angeletti A, Cravedi P.

Urgent Peritoneal Dialysis in Patients With COVID-19 and Acute Kidney Injury: A Single-Center Experience in a Time of Crisis in the United States

Sourial MY, Sourial MH, Dalsan R, Graham J, Ross M, Chen W, Golestaneh L.

Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response

Serrano OK, Kutzler HL, Rochon C, Radojevic JA, Lawlor MT, Hammond JA, Gluck J, Feingold AD, Jaiswal A.

Acute kidney injury in critically ill patients with COVID-19

Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L.

COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response

Ryan PM, Caplice N.

Comment on "ACE inhibitors and COVID-19: We don't know yet"

Ilcol TB, Cure E, Cumhur Cure M.

Association between renin-angiotensin system inhibitors and COVID-19 complications

Liabeuf S, Moragny J, Bennis Y, Batteux B, Brochot E, Schmit JL, Lanoix JP, Andrejak C, Ganry O, Slama M, Maizel J, Mahjoub Y, Masmoudi K, Gras-Champel V.

[Preliminary report on the Covid-19 outbreak in Valle d'Aosta dialysis centers]

Manes M, Radin E, Pell√π V, Molino A, Gabrielli D, Paternoster G, Parodi E, Priante L, Catania A, Doveri G.

[Standard procedures in dialysis during the Covid-19 epidemic]

Ippolito M, Di Tria GB, Aldrigo C, Ricci M, Zoni U, Giordano A, Cozzolino M.

[Healthcare, European Stability Mechanism and public funding following the Covid-19 pandemic]

Spampinato L.

Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?

Rodriguez-Cubillo B, Moreno de la Higuera MA, Lucena R, Valdes Franci E, Hurtado M, Calvo Romero N, Rodriguez Moreno A, Valencia D, Velo M, Sagastagoitia Fornie I, Sanchez-Fructuoso AI.

Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study

Bidulka P, Iwagami M, Mansfield KE, Kalogirou F, Wong AYS, Douglas IJ, Smeeth L, Summers C, Tomlinson LA.

Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient

Chenna A, Konala VM, Gayam V, Naramala S, Adapa S.

[The RAAS and SARS-CoV-2: A riddle to solve]

Choi M, Aiello EA, Ennis IL, Villa-Abrille MC.

[Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019]

Zhang J, Li J, Su L, Yang J, Jiang X, Jiang N, Lei Y, He L, Lu Q, Shen S, Chen F, Peng Z.

COVID-19 Experience in Hemodialysis Patients: A Cue for Therapeutic Heparin-Based Strategies?

Pisani A, Rizzo M, Angelucci V, Riccio E.

Continuous Renal Replacement Therapy for a Patient with Severe COVID-19

Katagiri D, Ishikane M, Ogawa T, Kinoshita N, Katano H, Suzuki T, Fukaya T, Hinoshita F, Ohmagari N.

ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19

Pinto BGG, Oliveira AER, Singh Y, Jimenez L, Gonçalves ANA, Ogava RLT, Creighton R, Peron JPS, Nakaya HI.

Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications

Hrenak J, Zorad S, Simko F.

Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China

Chen D, Li X, Song Q, Hu C, Su F, Dai J, Ye Y, Huang J, Zhang X.

Atypical Presentation of Novel Coronavirus Disease 2019 in a Peritoneal Dialysis Patient

Bose S, Adapa S, Konala VM, Gopalreddy H, Sohail S, Naramala S, Kondakindi H, Muppidi V, Ramachandran MV, Juran PJ, Aeddula NR.

Thrombotic microangiopathy in a patient with COVID-19

Jhaveri KD, Meir LR, Flores Chang BS, Parikh R, Wanchoo R, Barilla-LaBarca ML, Bijol V, Hajizadeh N.

Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19

Habib MB, Sardar S, Sajid J.

Canadian Society of Nephrology COVID-19 Rapid Response Team Home Dialysis Recommendations

Home Dialysis Workgroup Members:, Copland M, Hemmett J, MacRae JM, McCormick B, McCormick M, Qirjazi E, Singh RS, Zimmerman D.

COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship

Alcocer-Díaz-Barreiro L, Cossio-Aranda J, Verdejo-Paris J, Odin-de-Los-Ríos M, Galván-Oseguera H, Álvarez-López H, Alcocer-Gamba MA.

Risk following a SARS-CoV-2 exposure from a nocturnal hemodialysis patient utilizing continuous positive airway pressure (CPAP)

Lowe CF, Kiaii M, Aparicio L, Chinybaeva L, Coughlin S, Sekirov I, Morshed M, Leung V.

Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!

Tomasa-Irriguible TM, Martínez-Vega S, Mor-Marco E, Herraiz-Ruiz A, Raguer-Pardo L, Cubells-Larrosa C.

Incidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients:A Single-Center Experience

Arslan H, Musabak U, Ayvazoglu Soy EH, Kurt Azap O, Sayin B, Akcay S, Haberal KM, Akdur A, Yildirim S, Haberal M.

Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience

Akdur A, Karakaya E, Ayvazoglu Soy EH, Alshalabi O, Kirnap M, Arslan H, Ulubay G, Hekimoglu K, Moray G, Haberal M.

Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?

Tralhão A, Moita LF, Póvoa P.

Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: a stochastic simulation and machine learning study

Massie AB, Boyarsky BJ, Werbel WA, Bae S, Chow EK, Avery RK, Durand CM, Desai N, Brennan D, Garonzik-Wang JM, Segev DL.

COVID-19 in recent kidney transplant recipients

Shingare A, Bahadur MM, Raina S.

Renin-angiotensin system inhibition in COVID-19 patients

de Vries AAF.

Recommendation from Peking Union Medical College Hospital for urgent hemodialysis during the COVID-19 pandemic

Chen G, Hu R, Wang Y, Zhao X, Zhou Y, Song D, Xia J, Qin Y, Chen L, Li X.

Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19

Adamsick ML, Gandhi RG, Bidell MR, Elshaboury RH, Bhattacharyya RP, Kim AY, Nigwekar S, Rhee EP, Sise ME.

Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease

Liaudet L, Szabo C.

Peritoneal dialysis for COVID-19-associated acute kidney injury

Nagatomo M, Yamada H, Shinozuka K, Shimoto M, Yunoki T, Ohtsuru S.

COVID-19 Attacks the Kidney: Ultrastructural Evidence for the Presence of Virus in the Glomerular Epithelium

Abbate M, Rottoli D, Gianatti A.

COVID-19 and End Stage Renal Disease

Gustavo B, Lima E, Tome A.

Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives

Felice C, Nardin C, Di Tanna GL, Grossi U, Bernardi E, Scaldaferri L, Romagnoli M, Tonon L, Cavasin P, Novello S, Scarpa R, Farnia A, De Menis E, Rigoli R, Cinetto F, Pauletto P, Agostini C, Rattazzi M.

COVID-19 infection results in alterations of the kynurenine pathway and fatty acid metabolism that correlate with IL-6 levels and renal status

Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, Hudson KE, Zimring JC, Hansen KC, Hod EA, Spitalnik SL, D'Alessandro A.

Acute Kidney Injury in Hospitalized Patients with COVID-19

Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Baweja M, Campbell K, Chun N, Chung M, Deshpande P, Farouk SS, Kaufman L, Kim T, Koncicki H, Lapsia V, Leisman S, Lu E, Meliambro K, Menon MC, Rein JL, Sharma S, Tokita J, Uribarri J, Vassalotti JA, Winston J, Mathews KS, Zhao S, Paranjpe I, Somani S, Richter F, Do R, Miotto R, Lala A, Kia A, Timsina P, Li L, Danieletto M, Golden E, Glowe P, Zweig M, Singh M, Freeman R, Chen R, Nestler E, Narula J, Just AC, Horowitz C, Aberg J, Loos RJF, Cho J, Fay

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19

Khera R, Clark C, Lu Y, Guo Y, Ren S, Truax B, Spatz ES, Murugiah K, Lin Z, Omer SB, Vojta D, Krumholz HM.

Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2

Emilsson V, Gudmundsson EF, Aspelund T, Jonsson BG, Gudjonsson A, Launer LJ, Jennings LL, Gudmundsdottir V, Gudnason V.

SARS-CoV-2 receptor networks in diabetic kidney disease, BK-Virus nephropathy and COVID-19 associated acute kidney injury

Menon R, Otto EE, Sealfon R, Nair V, Wong AK, Theesfeld CL, Chen X, Wang Y, Boppana A, Kasson PM, Schaub JA, Berthier CC, Eddy S, Lienczewski CC, Godfrey B, Dagenais SL, Sohaney R, Hartman J, Fermin D, Subramanian L, Looker HC, Mariani LH, Naik AS, Nelson RG, Troyanskaya OG, Kretzler M.

Hyponatremia: A Possible Immuno-Neuroendocrine Interface with COVID-19 in a Kidney Transplant Recipient

Tantisattamo E, Reddy UG, Duong DK, Ferrey AJ, Ichii H, Dafoe DC, Kalantar-Zadeh K.

Covid-19: the renin-angiotensin system imbalance hypothesis

Lanza K, Perez LG, Costa LB, Cordeiro TM, Palmeira VA, Ribeiro VT, Simões E Silva AC.

COVID-19 in dialysis patients in Japan: Current status and guidance on preventive measures

Kikuchi K, Nangaku M, Ryuzaki M, Yamakawa T, Hanafusa N, Sakai K, Kanno Y, Ando R, Shinoda T, Nakamoto H, Akizawa T.

Infection Control Precautions and Care Delivery in Hemodialysis Unit during Coronavirus Disease 2019 Outbreak: A Case Series

Hu SC, Fu EQ, Fan JF, Ye QQ, Xia C, Gan TE, Ma HZ.

Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?

Huang Y, Xie C, Chen X, Hong Q, Huang H.

Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic

Chua HR, Laren GM, Choong LH, Chionh CY, Khoo BZE, Yeo SC, Sewa DW, Ng SY, Choo JC, Teo BW, Tan HK, Siow WT, Agrawal R, Tan CS, Vathsala A, Tagore R, Seow TY, Khatri P, Hong WZ, Kaushik M.

Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab

Gautier-Vargas G, Baldacini C, Benotmane I, Keller N, Perrin P, Moulin B, Caillard S.

Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection

Kemmner S, Guba M, Schönermarck U, Stangl M, Fischereder M.

Interleukin-17: a potential therapeutic target in COVID-19

Mendoza VMM.

COVID-19 pneumonia in a dual heart-kidney recipient

Stachel MW, Gidea CG, Reyentovich A, Mehta SA, Moazami N.

Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury

Lim JH, Park SH, Jeon Y, Cho JH, Jung HY, Choi JY, Kim CD, Lee YH, Seo H, Lee J, Kwon KT, Kim SW, Chang HH, Kim YL.

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Feldman A, D'Andréa Saba Arruda G, de Souza AS, de Albuquerque DC, Mazza L, Santos MF, Salvador NZ, Gibson CM, Granger CB, Alexander JH, de Souza OF; BRACE CORONA investigators.

The War We Call COVID-19: A Letter From the Front in New York

Parikh R, Khanin Y; Northwell Nephrology Fellows.

Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence

Turgeon RD, Zieroth S, Bewick D, Chow CM, Clarke B, Cowan S, Fordyce CB, Fournier A, Gin K, Gupta A, Hardiman S, Jackson S, Lau B, Leong-Poi H, Mansour S, Marelli A, Quraishi AR, Roifman I, Ruel M, Sapp J, Singh G, Small G, Virani S, Wood DA, Krahn A.

Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients

Calò LA, Davis PA, Rigato M, Sgarabotto L.

Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality

Cannata F, Chiarito M, Reimers B, Azzolini E, Ferrante G, My I, Viggiani G, Panico C, Regazzoli D, Ciccarelli M, Voza A, Aghemo A, Li H, Wang Y, Condorelli G, Stefanini GG.

Antihypertensive drugs in COVID-19 infection

Pinto-Sietsma SJ, Flossdorf M, Buchholz VR, Offerhaus J, Bleijendaal H, Beudel M, Volders PGA, Ter Bekke RMA, Dormans T, Zwetsloot PP, de Jager P, Massberg S, Rämer P, Wendtner C, Hoffmann E, Rothe K, Feihl S, Kessler T, Pinto YM, Schunkert H.

Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations

Snyder EM, Johnson BD.

Disaster Response to the COVID-19 Pandemic for Patients with Kidney Disease in New York City

Division of Nephrology, Columbia University Vagelos College of Physicians Working Group, New York, New York.

Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea

Jung HY, Lim JH, Kang SH, Kim SG, Lee YH, Lee J, Chang HH, Kim SW, Choi JY, Cho JH, Kim CD, Kim YL, Park SH.

Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs

Ruilope LM, Tamargo J, Ruiz-Hurtado G.

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, Li Q, Li W, Yang S, Zhao X, Zhao Y, Wang H, Liu Y, Yin Z, Zhang R, Wang R, Yang M, Hui C, Wijns W, McEvoy JW, Soliman O, Onuma Y, Serruys PW, Tao L, Li F.

Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"

Cohen JB, Hanff TC, South AM, Sparks MA, Hiremath S, Bress AP, Byrd JB, Chirinos JA.

Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"

Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Wang Y, Yuan Y, Rohit L, Liu PP, Li H.

Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, Wang M, Li S, Morita H, Altunbulakli C, Reiger M, Neumann AU, Lunjani N, Traidl-Hoffmann C, Nadeau K, O'Mahony L, Akdis CA, Sokolowska M.

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?

Shyh GI, Nawarskas JJ, Cheng-Lai A.

COVID-19 and kidney transplantation: an Italian Survey and Consensus

Vistoli F, Furian L, Maggiore U, Caldara R, Cantaluppi V, Ferraresso M, Zaza G, Cardillo M, Biancofiore G, Menichetti F, Russo A, Turillazzi E, Di Paolo M, Grandaliano G, Boggi U; Italian National Kidney Transplantation Network; the Joint Committee of the Italian Society of Organ Transplantation and the Italian Society of Nephrology.

Advanced renal cell carcinoma and COVID-19 - a personal perspective

Ged Y, Markowski MC, Pierorazio PM.

Covid-19: Pandemic is having "severe" impact on non-communicable disease care, WHO survey finds

Dyer O.

Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality

Zhou F, Liu YM, Xie J, Li H, Lei F, Yang H, Qin JJ, Cai J, Zhang XJ, Wu B, Xia M, Xiang D, Yang C, Ma XL, Xu Q, Lu Z, Lu H, Xia X, Wang D, Liao X, Peng G, Yang J, Huang X, Zhang BH, Yuan Y, Wei X, Liu PP, Wang Y, Zhang P, She ZG, Xia J, Li H.

Two hits to the renin-angiotensin system may play a key role in severe COVID-19

Tseng YH, Yang RC, Lu TS.

Review of the present features and the infection control challenges of COVID-19 pandemic in dialysis facilities

Lee JJ, Hwang SJ, Huang JF.

Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?

Philips CA, Kumbar S, Ahamed R, Augustine P.

COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy

Adapa S, Aeddula NR, Konala VM, Chenna A, Naramala S, Madhira BR, Gayam V, Balla M, Muppidi V, Bose S.

Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?

Bellastella G, Maiorino MI, Esposito K.

Role of point-of-care ultrasound during the COVID-19 pandemic: our recommendations in the management of dialytic patients

Vieira ALS, Pazeli J√∫nior JM, Bastos MG.

Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?

Koufakis T, Metallidis S, Zebekakis P, Ajjan RA, Kotsa K.

Renal Infarct in a COVID-19 Positive Kidney-Pancreas Transplant Recipient

Xu JJ, Samaha D, Mondhe S, Massicotte-Azarniouch D, Knoll G, Ruzicka M.

Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea

Cho JH, Kang SH, Park HC, Kim DK, Lee SH, Do JY, Park JW, Kim SN, Kim MS, Jin K, Kang GW, Park SH, Kim YL, Lee YK; Korean Society of Nephrology COVID-19 Task Force Team.

Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?

Bobkova I, Kamyshova E, Rudenko T, Stavrovskaya E, Moiseev S.

Kidney Infarction in Patients With COVID-19

Post A, den Deurwaarder ESG, Bakker SJL, de Haas RJ, van Meurs M, Gansevoort RT, Berger SP.

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19

Fishbane S, Hirsch JS.

COVID-19: ACE2centric infective disease?

Verdecchia P, Cavallini C, Spanevello A, Angeli F.

Selecting the Most Appropriate Oncological Treatment for Patients with Renal Masses During the COVID-19 Pandemic: Recommendations from a Referral Center

Moschovas MC, Mazzone E, Puliatti S, Mottrie A, Patel V.

Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis

Pirola CJ, Sookoian S.

COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome

Hu J, Zhang X, Zhang X, Zhao H, Lian J, Hao S, Jia H, Yang M, Lu Y, Xiang D, Cai H, Zhang S, Gu J, Ye C, Yu G, Jin C, Zheng L, Yang Y, Sheng J.

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Singh AK, Gupta R, Misra A.

Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Mahajan K, Gaur N.

Food protein-derived antihypertensive peptides in the COVID-19 pandemic: friends of foes?

Goudarzi M, Garavand F, Madadlou A, Fogliano V.

Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure"

Fedson DS, Opal SM, Rordam OM.

De-isolation of COVID-19-positive hemodialysis patients in the outpatient setting: a single-center experience

Dudreuilh C, Kumar N, Moxham V, Hemsley C, Goldenberg S, Moutzouris DA.

Tubuloreticular inclusions in COVID-19-related collapsing glomerulopathy

Gaillard F, Ismael S, Sannier A, Tarhini H, Volpe T, Greze C, Verpont MC, Zouhry I, Rioux C, Lescure FX, Buob D, Daugas E.

Collapsing glomerulopathy in a COVID-19 patient

Kissling S, Rotman S, Gerber C, Halfon M, Lamoth F, Comte D, Lhopitallier L, Sadallah S, Fakhouri F.

Managing the COVID-19 pandemic: international comparisons in dialysis patients

Kliger AS, Cozzolino M, Jha V, Harbert G, Ikizler TA.

Could ferritin help the screening for COVID-19 in hemodialysis patients?

Bataille S, Pedinielli N, Bergounioux JP.

Adding insult to injury: kidney replacement therapy during COVID-19 in India

Ramachandran R, Jha V.

COVID-19 in elderly kidney transplant recipients

Crespo M, José Pérez-Sáez M, Redondo-Pachón D, Llinàs-Mallol L, Montero MM, Villar J, Arias-Cabrales C, Buxeda A, Burballa C, Vázquez S, López T, Moreno F, Mir M, Outón S, Sierra A, Collado S, Barrios C, Rodríguez E, Sans L, Barbosa F, Cao H, Arenas MD, Güerri-Fernández R, Horcajada JP, Pascual J.

Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19

Dabaghian F, Khanavi M, Zarshenas MM.

[Renal Monomorphology in COVID-19 with Acute Renal Insufficiency]

Tuma J, Neugebauer F, Rohacek M, Serra A.

SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism

Mori J, Oudit GY, Lopaschuk GD.

Does gallium-citrate have yet another story to tell? Lessons relevant to the COVID-19 era

Zuckier LS, Valdivia AY, Zamora E.

Acute kidney injury associated with COVID-19: another extrapulmonary manifestation

Barros Camargo L, Quintero Marzola ID, Cárdenas Gómez JC, Mendoza Daza LT, Quintana Pájaro L.

Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome as a Presentation of Coronavirus Disease 2019

Prabhu V, Hsu E, Lestin S, Soltanianzadeh Y, Hadi S.

Presentation and Outcomes of Patients with ESKD and COVID-19

Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, Gharavi AG, Mohan S, Husain SA.

The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system

Offringa A, Montijn R, Singh S, Paul M, Pinto YM, Pinto-Sietsma SJ.

Clinical features of hemodialysis patients with COVID-19: a single-center retrospective study on 32 patients

Du X, Li H, Dong L, Li X, Tian M, Dong J.

The case of Complement activation in COVID-19 multiorgan impact

Noris M, Benigni A, Remuzzi G.

Focus on kidney disease among the coronavirus disease 2019 patients: A comparative perspective between China, Italy and the United States

Chen L, Guo C.

COVID-19 and Renin-Angiotensin system inhibition - role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?

Aleksova A, Ferro F, Gagno G, Cappelletto C, Santon D, Rossi M, Ippolito G, Zumla A, Beltrami AP, Sinagra G.

Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis

Guo X, Zhu Y, Hong Y.

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing

Palmer K, Monaco A, Kivipelto M, Onder G, Maggi S, Michel JP, Prieto R, Sykara G, Donde S.

Catastrophic Intracranial Hemorrhage in Two Critically Ill Patients with COVID-19

Carroll E, Lewis A.

Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City

Yamada T, Mikami T, Chopra N, Miyashita H, Chernyavsky S, Miyashita S.

Safety and Efficacy of Bedside Peritoneal Dialysis Catheter Placement in the COVID-19 Era: Initial Experience at a New York City Hospital

Vigiola Cruz M, Bellorin O, Srivatana V, Afaneh C.

The impact of the COVID-19 pandemic on renal transplantation in the UK

Sharma V, Shaw A, Lowe M, Summers A, van Dellen D, Augustine T.

Covid-19 and acute kidney injury in hospital: summary of NICE guidelines

Selby NM, Forni LG, Laing CM, Horne KL, Evans RD, Lucas BJ, Fluck RJ.

High prevalence of asymptomatic COVID-19 in haemodialysis: learning day by day in the first month of the COVID-19 pandemic

Albalate M, Arribas P, Torres E, Cintra M, Alcázar R, Puerta M, Ortega M, Procaccini F, Martin J, Jiménez E, Fernandez I, de Sequera P; Grupo de Enfermería HUIL; Grupo enfermería HUIL.

Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study

Sun DQ, Wang TY, Zheng KI, Targher G, Byrne CD, Chen YP, Zheng MH.

Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19

Dabaghian F, Khanavi M, Zarshenas MM.

COVID-19 in an HIV-positive Kidney Transplant Recipient

Kumar RN, Tanna SD, Shetty AA, Stosor V.

Why the Use of Angiotensin II May Be a Fatal Mistake in Covid-19

Ferreira J, Mcmanus J, Jankowski CA, Searcy R.

Moderately Severe Diarrhea and Impaired Renal Function With COVID-19 Infection

Cappell MS.

Hemodialysis Vascular Access Care during the COVID-19 Pandemic

Yang CY, Wang YF, Ho Y, Wu CH, Lee CY, Tarng DC.

COVID-19: Nephrology preparedness checklist

Geara AS, Neyra JA.

Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?

Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A.

Nothing will ever be as before. Reflections on the COVID-19 epidemics by nephrologists in eleven countries

ICONA members, Gambaro G, Piccoli GB.

A view from the front line of the COVID-19 war

Carrara C, Cappelletti L, Portalupi V.

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Perna AF, Capolongo G, Trepiccione F, Simeoni M, Zacchia M, Ingrosso D.

The interplay of Hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19

Tsioufis C, Dimitriadis K, Tousoulis D.

Cost-Related Antihypertensive Medication Nonadherence:Action in the Time of COVID-19 and Beyond

Tajeu GS, Muntner P.

Successful recovery from severe COVID-19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab

Lauterio A, Valsecchi M, Santambrogio S, De Carlis R, Merli M, Calini A, Centonze L, Buscemi V, Bottiroli M, Puoti M, Fumagalli R, De Carlis L.

[Renin-angiotensin system blockers and COVID-19 infection]

Ruilope LM, Garcia Donaire JA, de la Sierra A.

[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]

Pallarés Carratalá V, Górriz-Zambrano C, Morillas Ariño C, Llisterri Caro JL, Gorriz JL.

Electron Microscopic Investigations in COVID-19: Not all Crowns Are Coronas

Roufosse C, Curtis E, Moran L, Hollinshead M, Cook T, Hanley B, Horsfield C, Neil D.

What Solid Organ Transplant Healthcare Providers should know about Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19

Wong SY, Brubaker AL, Wang AX, Taiwo AA, Melcher ML.

Sodium status and kidney involvement during COVID-19 infection

Post A, Dullaart RPF, Bakker SJL.

Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic

Anders HJ, Bruchfeld A, Fernandez Juarez GM, Floege J, Goumenos D, Turkmen K, van Kooten C, Tesar V, Segelmark M.

Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, Huang B, Fu S, Tan Y, Sun J, Li X.

COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure

Siniorakis E, Arvanitakis S, Nikolopoulos I, Elkouris M.

Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection

Gnavi R, Demaria M, Picariello R, Dalmasso M, Ricceri F, Costa G.

Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study

Jung SY, Choi JC, You SH, Kim WY.

Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What's next for ACE2?

Patel AB, Verma A.

How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion

Maggiore U, Abramowicz D, Crespo M, Mariat C, Mjoen G, Peruzzi L, Sever MS, Oniscu GC, Hilbrands L, Watschinger B.

Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease

Jennings GL.

Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?

Silhol F, Sarlon G, Deharo JC, Vaïsse B.

An unusual case of severe acute hyponatremia in patient with COVID-19 infection

De La Flor Merino JC, Mola Reyes L, Linares Gravalos T, Roel Conde A, Rodeles Del Pozo M.

Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19

Bozkurt B, Kovacs R, Harrington B.

A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19

Nalesso F, Garzotto F, Cattarin L, Gobbi L, Qassim L, Sgarabotto L, Tiberio I, Calò LA.

The Dilemma of Renin Angiotensin System Blockers in Coronavirus Disease (Covid-19): Insights on the Lung Fluid Handling and Gas Exchange in Heart Failure Patients

Guazzi M, Moroni A.

Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection

Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST, Abbott W, Mears E, Steele R, McKee J, Muscroft-Taylor A, Ameratunga S, Medlicott N, Das S, Rolleston W, Quiñones-Mateu M, Petousis-Harris H, Jordan A.

COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain

Goicoechea M, Sánchez Cámara LA, Macías N, Muñoz de Morales A, González Rojas Á, Bascuñana A, Arroyo D, Vega A, Abad S, Verde E, García Prieto AM, Verdalles U, Barbieri D, Felipe Delgado A, Carbayo J, Mijaylova A, Pérez de José A, Melero R, Tejedor A, Rodriguez Benitez P, de José AP, Rodriguez Ferrero ML, Anaya F, Rengel M, Barraca D, Luño J, Aragoncillo I.

Visualization of putative coronavirus in kidney

Kissling S, Rotman S, Fakhouri F.

A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection

Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, Maffei C, Possenti S, Lucca B, Cortinovis R, Terlizzi V, Zappa M, Saccà C, Pezzini E, Calcaterra E, Piarulli P, Guerini A, Boni F, Gallico A, Mucchetti A, Affatato S, Bove S, Bracchi M, Costantino EM, Zubani R, Camerini C, Gaggia P, Movilli E, Bossini N, Gaggiotti M, Scolari F.

COVID-19 in Dialysis Patients: Adding a Few More Pieces to the Puzzle

Ikizler TA.

Multivesicular Bodies (MVB) Mimicking SARS-CoV-2 in patients without COVID-19

Calomeni E, Satoskar A, Ayoub I, Brodsky S, Rovin BH, Nadasdy T.

Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect AKI and other organ injury in critically ill patients with COVID-19

Edelstein CL, Venkatachalam MA, Dong Z.

Evidence that Renin-Angiotensin System Inhibitors Should not be Discontinued Due to the COVID-19 Pandemic

Carey RM, Wang JG.

SARS-CoV-2 infection in Spanish children with chronic kidney pathologies

Melgosa M, Madrid A, Alv√°rez O, Lumbreras J, Nieto F, Parada E, Perez-Beltr√°n V; Spanish Pediatric Nephrology Association.

Gustatory dysfunctions in COVID-19 patients: possible involvement of taste renin-angiotensin system (RAS)

Bigiani A.

Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics

D'Marco L, Puchades MJ, Romero-Parra M, Gorriz JL.

Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management

Liu M, Wang T, Zhou Y, Zhao Y, Zhang Y, Li J.

Management of acute kidney injury in COVID-19

Hassanein M, Thomas G, Taliercio J.

Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19

Furuhashi M, Moniwa N, Takizawa H, Ura N, Shimamoto K.

Impact of the COVID-19 Pandemic on the Management of End-Stage Renal Disease Patients

Li SY, Tang YS, Chan YJ, Tarng DC.

SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy

Pesaresi M, Pirani F, Tagliabracci A, Valsecchi M, Procopio AD, Busardò FP, Graciotti L.

Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19

Faguer S, Del Bello A, Abravanel F, Nicolau-Travers ML, Kamar N.

The kidney in COVID-19: protagonist or figurant?

Staico MF, Zaffanello M, Di Pietro G, Fanos V, Marcialis MA.

When a nephrology ward becomes a COVID-19 ward: the Cremona experience

Malberti F, Pecchini P, Marchi G, Foramitti M.

Lung ultrasound: a valuable tool for the assessment of dialysis patients with COVID-19

Reisinger N, Koratala A.

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies

Albini A, Di Guardo G, Noonan DM, Lombardo M.

Letter to the editor: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk score

Vavougios GD.

Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis

Oyelade T, Alqahtani J, Canciani G.

Acute Kidney Injury in COVID-19 Pandemic

Capuano I, Buonanno P, Riccio E, Pisani A.

Convalescent COVID-19 Patients on Hemodialysis: When Should We End Isolation?

Murt A, Altıparmak MR.

ACE Inhibitors and ARBs in Patients with COVID-19: Friend or Foe?

Shyh GI, Nawarskas JJ, Cheng-Lai A.

Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply

Vaduganathan M, Solomon SD.

Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19

Birnbaum RA.

Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19

Haug G, Eapen MS, Sohal SS.

Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19

Lubel J, Garg M.

Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against "SARS-CoV-2 nephropathy"

Rossi GM, Delsante M, Pilato FP, Gnetti L, Gabrielli L, Rossini G, Re MC, Cenacchi G, Affanni P, Colucci ME, Picetti E, Rossi S, Parenti E, Maccari C, Greco P, Di Mario F, Maggiore U, Regolisti G, Fiaccadori E.

Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19

Sarzani R, Giulietti F, Di Pentima C, Filipponi A, Spannella F.

Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators

Wang TD.

Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19

Dabaghian F, Khanavi M, Zarshenas MM.

Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19

Sarzani R, Giulietti F, Di Pentima C, Filipponi A, Spannella F.

Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019

Husain SA, Dube G, Morris H, Fernandez H, Chang JH, Paget K, Sritharan S, Patel S, Pawliczak O, Boehler M, Tsapepas D, Crew RJ, Cohen DJ, Mohan S.

COVID-19-associated nephritis: early warning for disease severity and complications?

Gross O, Moerer O, Weber M, Huber TB, Scheithauer S.

ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis

Zhang X, Yu J, Pan LY, Jiang HY.

Endovascular treatment of a ruptured pararenal abdominal aortic aneurysm in a COVID-19 patient: suggestions and case report

Rinaldi LF, Marazzi G, Marone EM.